NEO

NeoGenomics (NEO)

NeoGenomics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:NEO

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/04/30	20:30	Business Wire	NeoGenomics Reports First Quarter 2024 Results	NASDAQ:NEO	NeoGenomics Inc
2024/04/18	20:05	Business Wire	NeoGenomics Announces Senior Leadership Promotions	NASDAQ:NEO	NeoGenomics Inc
2024/04/09	20:00	Business Wire	NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024	NASDAQ:NEO	NeoGenomics Inc
2024/03/27	21:30	Business Wire	NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting	NASDAQ:NEO	NeoGenomics Inc
2024/03/20	20:00	Business Wire	NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report	NASDAQ:NEO	NeoGenomics Inc
2024/03/07	06:26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/03/05	07:33	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:NEO	NeoGenomics Inc
2024/03/01	21:05	Business Wire	NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference	NASDAQ:NEO	NeoGenomics Inc
2024/02/28	06:29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/02/28	06:28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/02/28	06:28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/02/28	06:27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/02/27	06:15	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:NEO	NeoGenomics Inc
2024/02/21	06:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/02/21	06:23	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:NEO	NeoGenomics Inc
2024/02/21	06:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NEO	NeoGenomics Inc
2024/02/21	06:05	Business Wire	NeoGenomics Reports Fourth Quarter and Full Year 2023 Results	NASDAQ:NEO	NeoGenomics Inc
2024/02/20	19:37	IH Market News	Market Cautiousness Ahead of Retail Giants’ Earnings; Oil Prices Dip	NASDAQ:NEO	NeoGenomics Inc
2024/02/16	06:26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:NEO	NeoGenomics Inc
2024/02/15	00:04	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:NEO	NeoGenomics Inc
2024/02/10	05:17	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:NEO	NeoGenomics Inc
2024/02/01	21:05	Business Wire	NeoGenomics Signs Working with Cancer Pledge in Support of Employees	NASDAQ:NEO	NeoGenomics Inc
2024/01/30	21:05	Business Wire	NeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024	NASDAQ:NEO	NeoGenomics Inc
2024/01/04	07:28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/01/02	21:05	Business Wire	NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:NEO	NeoGenomics Inc
2023/12/12	09:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2023/12/06	06:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2023/11/21	06:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2023/11/18	06:25	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:NEO	NeoGenomics Inc
2023/11/07	06:29	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NEO	NeoGenomics Inc